[Lipolytic enzyme activity in the tissues of various internal organs during Phepraset (IEM-366) therapy of experimental atherosclerosis].
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001011:Aorta / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D008049:Lipase / Q000378:metabolism*; D050356:Lipid Metabolism; D008099:Liver / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D011651:Pulmonary Artery / Q000201:enzymology; D011817:Rabbits
D000924:Anticholesteremic Agents; D005230:Fatty Acids, Nonesterified; D002784:Cholesterol; D008049:Lipase
Aktivnost' lipoliticheskikh fermentov tkaneĭ nekotorykh vnutrennikh organov pri terapii éksperimental'nogo ateroskleroza fepratsetom (IEM-366)